Domestic Production and Incentives Propel India to Global Med‑Tech Partner
India is emerging as a reliable partner in the worldwide medical technology market, driven by robust domestic production and a steady decline in import dependence.
Prime Minister Modi shared the Health Minister’s analysis of how initiatives like the Production‑Linked Incentive (PLI) plan, medical device parks, and the Pharmaceutical‑MedTech Innovation Programme (PRIIP) are reshaping the industry.
The PLI programme alone has enabled the launch of over 50 state‑of‑the‑art medical devices, while a surge in foreign capital signals increasing investor trust.
Reduced import reliance is expected to fortify supply chains, lower costs, and improve the availability of sophisticated imaging systems, implants and ICU gear across the nation.
The minister also underscored emerging opportunities in artificial intelligence, software‑as‑a‑medical‑device (SaMD), connected devices, robotics and remote diagnostics, all of which could redefine health services in the coming years.